Early trials of a one-size-fits-all pancreatic cancer vaccine indicates that it may be effective at preventing recurrence of difficult-to-treat pancreatic cancers. According to NBC News, the vaccine targets KRAS gene mutations, which are associated with up to 90 percent of pancreatic cancers and 40 percent of colorectal cancers. The vaccine stimulates an immune response that targets and destroys cells with KRAS mutations.
Related Posts
Do some hearts just need a little rest?
There is no cure for heart failure, although drugs can slow its progress, but a new study suggests that the heart might improve if it just gets some rest….
The benefits of breastfeeding over formula
There are a striking number of benefits for babies that breastfeed, and every expecting mother should strongly consider providing nutrition to their…
Dreaming of candles on the tree? Try a virtual tree instead
Candles on Christmas trees went out of vogue more than a century ago, and good riddance — open flames balanced on increasingly dry evergreen branches is…